Mad Money with Jim Cramer BioReference Laboratories Executive Chairman Jon Cohen gives an update on coronavirus testing in the NBA and NFL, clearing the air behind so-called “false positive” diagnoses in football. Click here for original post on Mad Money with Jim Cramer
Search Results for: hair test
CNBC BioReference Executive Chairman Dr. Jon Cohen joined Jim Cramer on “Mad Money” to discuss efforts to roll out mass testing all over America. Click here for original post on CNBC
PR Newswire Transaction to extend Labcorp’s leadership in oncology and expand access to the company’s high-quality clinical laboratory services BURLINGTON, N.C. and MIAMI, March 11, 2025 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational biopharmaceutical and diagnostics company, announced today that they have entered into an agreement for Labcorp to acquire select assets of BioReference […]
08
Dec
Dec
MIAMI, Dec. 08, 2021 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) today announced that the U.S. Food and Drug Administration (FDA) has approved OPKO’s 4Kscore Test. This test is approved for use in men age 45 and older who have not had a prior prostate biopsy or are biopsy negative and have an age-specific abnormal total PSA and/or […]
Press Release
BioReference Laboratories Announces Readiness for COVID-19 Testing if the Omicron COVID-19 Variant Emerges in The U.S.
29
Nov
Nov
ELMWOOD PARK, N.J., November 29, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), announced COVID-19 testing preparedness for the Omicron Variant. BioReference’s PCR diagnostic tests for SARS-CoV-2 COVID-19 are based on recognizing specific RNA target genes that are common to all coronaviruses. To date, the diagnostic targets have not changed with the novel […]
Press Release
Rite Aid, in Partnership with the U.S. Department of Health and Human Services, BioReference Laboratories and New York State, Announces ‘Back to School’ COVID-19 Testing Program
26
Aug
Aug
New York students K-12 will have the opportunity for COVID-19 testing prior to or at the start of the 2021-2022 school year through Rite Aid and BioReference CAMP HILL, Pa. (August 26, 2021) – Rite Aid (NYSE: RAD) and the U.S. Department of Health and Human Services (HHS), together with BioReference Laboratories, Inc., an OPKO Health […]
Press Release
BioReference Laboratories Acquires U.S. Ariosa Centralized Laboratory Prenatal Testing Business
16
Aug
Aug
ELMWOOD PARK, N.J., August 16, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the acquisition of the U.S. Ariosa centralized laboratory prenatal testing business from Roche. Ariosa’s non invasive prenatal screening (NIPS) test, the Harmony Prenatal Test, is one of the most widely studied tests utilized in prenatal screening. The test has been performed in […]
Press Release
BioReference Laboratories Announces First COVID-19 Testing Program for Cruise Industry
22
Jun
Jun
MIAMI, June 22, 2021 /PRNewswire/ — BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced a COVID-19 testing program for U.S. based crew and guests who cruise with Royal Caribbean Group, helping provide a safe environment for travelers. Under the agreement, unvaccinated guests will be required to undergo rapid, point-of-care PCR COVID-19 prior to embarking. These guests will […]
Press Release
Major League Soccer Renews BioReference Laboratories as COVID-19 Testing Provider for Second Year
27
Apr
Apr
BioReference continues providing PCR molecular and rapid COVID-19 testing to Major League Soccer players, match officials, and Club and League employees BioReference is testing New England Revolution Fans for COVID-19 at Gillette Stadium in Foxborough, Massachusetts ELMWOOD PARK, N.J., April 27, 2021 – BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its renewal as […]
NJ BIZ BioReference Laboratories Inc. in Elmwood Park entered into a COVID-19 testing agreement for players and staff, stadium employees and league staff for the 2021 Major League Baseball season. Under the agreement announced April 1, BioReference will provide on-site rapid PCR COVID-19 testing to all 30 MLB teams, leveraging Mesa Biotech’s Accula System. Testing begins on April 1, which […]
